Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sol-Gel Technologies receivables from 2016 to 2025. Receivables can be defined as the total amount of collectibles for a company

Sol-Gel Technologies Receivables 2016-2025 | SLGL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sol-Gel Technologies receivables from 2016 to 2025. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$15.5B
Dr Reddy's Laboratories (RDY)	$11.4B
BridgeBio Pharma (BBIO)	$6.4B
Bausch Health Cos (BHC)	$1.9B
Supernus Pharmaceuticals (SUPN)	$1.7B
Amphastar Pharmaceuticals (AMPH)	$1.1B
Personalis (PSNL)	$282M
Taysha Gene Therapies (TSHA)	$254M
Assembly Biosciences (ASMB)	$75M
Evoke Pharma (EVOK)	$3M
Teligent (TLGT)	$0M